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Abstract
Background: Selection of influential genes with microarray data often faces the difficulties of a
large number of genes and a relatively small group of subjects. In addition to the curse of
dimensionality, many gene selection methods weight the contribution from each individual subject
equally. This equal-contribution assumption cannot account for the possible dependence among
subjects who associate similarly to the disease, and may restrict the selection of influential genes.
Results: A novel approach to gene selection is proposed based on kernel similarities and kernel
weights. We do not assume uniformity for subject contribution. Weights are calculated via
regularized least squares support vector regression (RLS-SVR) of class levels on kernel similarities
and are used to weight subject contribution. The cumulative sum of weighted expression levels are
next ranked to select responsible genes. These procedures also work for multiclass classification.
We demonstrate this algorithm on acute leukemia, colon cancer, small, round blue cell tumors of
childhood, breast cancer, and lung cancer studies, using kernel Fisher discriminant analysis and
support vector machines as classifiers. Other procedures are compared as well.
Conclusion: This approach is easy to implement and fast in computation for both binary and
multiclass problems. The gene set provided by the RLS-SVR weight-based approach contains a less
number of genes, and achieves a higher accuracy than other procedures.
Background
The development of microarray technique allows us to
observe simultaneously a great number of messenger RNAs
(mRNA). These microarray data can be used to cluster
patients,ortodeterminewhichgenesarecorrelatedwiththe
disease. Recently, Golub et al. [1] and Brown et al. [2]
considered the classification of known disease status (called
class prediction or supervised learning) using microarray
data. These gene expression values are recorded from a large
number of genes, where only a small subset is associated
with the disease class labels. In the community of machine
learning, many procedures, termed as gene selection,
variable selection, or feature selection, have been developed
to identify or to select a subset of genes with distinctive
features. However, both the proportion of "relevant" genes
and the number of tissues (subjects) are usually small, as
compared to the number of genes, and thus lead to
difficulties in finding a stable solution. The dimension
reductionforgeneselection as wellas for finding influential
genes is essential.
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between genes and class labels, where the correlation
measure can be the Pearson correlation [3], signal-to-
noise ratio [1], t-statistic [4], ratio of between-group sum
of squares to within-group sum of squares [5], informa-
tion-based criteria [6], information of intra-class varia-
tions and inter-class variations [7], or others (see the
review paper by Saeys et al. [8]). These procedures are
univariate in the sense that the correlation between genes
and disease is examined for each individual gene.
Although they are easy to perform, these methods
consider one gene at a time and ignore the gene-gene
interaction. Alternative methods are multivariate
approaches, such as Markov blanket filter [9-11] and a
fast correlation based filter solution [12]. These multi-
variate correlation methods, however, can be computa-
tionally heavy, as compared with the univariate
procedures.
Different from the correlation-based approaches, other
researchers assess the significance of features based on
the classification accuracy, a measure of performance in
classifying the testing set. Most approaches adopt
support vector machines (SVMs). For instance, the
sparsity of 1-norm SVM is used as an exclusion index
of features [13, 14]. Guyon et al. [15] introduced a
backward selection method that removes at each step the
gene with the smallest square weight of SVM coefficient,
called recursive feature elimination (RFE). In contrast,
Lee et al. [16] proposed a forward selection method,
called incremental forward feature selection (IFFS). It
grows from a small subset and defines a positive gap
parameter indicating whether to include a new feature or
not. Some genetic-algorithm-based searching approaches
have been proposed as well [17, 18].
Other feature selection methods utilized regression
technique and/or focused on the extension to multiclass
p r o b l e m s .L e ee ta l .[ 1 9 ]s e l e c t e dt h ei n f l u e n t i a lg e n e sv i a
a hierarchical probit regression model. They estimated,
via Markov chain Monte Carlo (MCMC) method, the
probability that the j-th gene is influential and the
probability that the i-th sample is a cancer tissue at a
fixed gene. Sha et al. [20] have extended this approach to
multiclass responses. However, no empirical result was
presented. Yeung et al. [21] adopted a Bayesian model
average (BMA) approach for the case of binary classes.
They also discussed the extension to multiclass labels
using a specially designed matrix. Similar to Lee et al.
[19], Zhou et al. [22] extended the probit model into a
multinomial model to select the strongest genes for
multiclass problems.
In this article, we also focus on cases with multiclass
responses. We select genes based on their "importance"
determined by a weighted average of expression levels. If
tissue samples share similar expression levels, they will
be weighted similarly when calculating the importance
measure for each gene. If the levels vary, then the weights
will not be the same. In other words, the expressions are
weighted differently. These weights are kernel weights
derived from the regularized least squares support vector
regression (RLS-SVR, [23]). T h ea d v a n t a g e so fR L S - S V R
algorithm include less computational problems caused
by attributes dependence, and efficient estimates of
regression coefficients indicating association between
similarity measure and class response. We employ these
estimates to formulate subject weights, and then proceed
to selection and classification. The advantages of our
approach are the flexibility in including a non-uniform
weighting scheme, the ability of performing multiclass
classification, and the fast and easy implementation. In
the following, we introduce the proposed gene selection
algorithm, discuss briefly the RLS-SVR, and outline
classification rules based on the selected genes. Empirical
analyses of five data sets from acute leukemia, colon
cancer, small round blue tumors, breast cancer, and lung
cancer studies are presented. The proposed algorithm is
demonstrated and its performance is compared with the
analysis conducted by others [6, 7, 15, 16, 19, 21, 22].
Method
Let {( , )} xy iii
n
=1 denote the training data set, where xi Œ
X ⊂ R
p a r eg e n ee x p r e s s i o n sa n dyi Œ {1, ..., J} are class
memberships such as the cancer types or disease states.
The traditional gene selection methods assume every
sample subject (or sample tissue) with equal contribu-
t i o na n dt h u sw e i g h ta l ls a m p l e su n i f o r m l y .O u r
proposal considers every sample differently and assigns
various weights via the RLS-SVR. In the following we
introduce the principle of the proposed gene selection
procedures, and illustrate the RLS-SVR algorithm for
assigning weights and SVM classification.
Principle of gene selection
Before proceeding to the procedures of gene selection, it
is necessary to standardize the gene expression data. Let
A be the collection of standardized input data with
subjects by row and genes by column,
A
x
x
T
n
T
np
=
⎡
⎣
⎢
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# ,
where the vector xi denotes the standardized data of the
ith tissue, and A is standardized in such a way that each
row has mean zero, i.e., xij j
p
=
= ∑ 0
1 , and variance 1, i.e.,
xp ij j
p 2
1 1 / =
= ∑ ,f o ra l li =1 ,. . . ,n. Earlier gene selection
methods, as discussed in Introduction, regarded each
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of gene-disease association, and therefore used the
expressions directly in their selections. Tissues of similar
expressions, however, often contain some information
for further investigation. For example, some "clustering"
pattern may imply similar contributions to disease-gene
association. Therefore, these tissues should be assigned
with similar weights when computing the importance
measure for each gene. In addition, the similarity
between expression values can arise from similar
conditions in disease stages; while the difference may
be due to the different degrees of cellular mutations. In
other words, the weight on each tissue should depend on
its "closeness" to others and its association to disease
stages. In the following, we propose a weighting scheme
that accounts for the difference in contribution from
different subject tissues.
T h ef i r s tp r o c e d u r ei st om e a s u r et h ec l u s t e r i n gp a t t e r n
between tissues via a kernel function. The kernel
transformation maps data into a high dimensional
space, where data with similar characters locate closely.
Therefore, the kernel data [( , ) ] , k xx ij i j
n
=1 , denoted by
(A, A) for short, measure the between-subject similar-
ity (here subjects are the sample tissues). For instance,
the row-vector (xi, A)=( (xi, x1), (xi, x2), ..., (xi,
xn)) represents the similarity measures of gene expres-
sions between the ith subject and the rest. Thus, tissues
sharing similar expression levels will produce a large
kernel value indicating a high similarity. Next, we
determine the relative contribution of individual
sample tissue by the regression coefficients of class
labels on tissue similarities. This regression step is
performed via RLS-SVR (more discussions about RLS-
SVR and derivations are in next section) to determine
the weights. The resulting n regression coefficients
ˆ w 1,..., and ˆ w n, denoted as a vector ˆ w ,r e p r e s e n tt h e
correlations between (xi, A)a n dy for i =1 ,. . . ,n,a n d
are regarded as the contributions of individual tissues.
These numbers ˆ w are called kernel weights. The use of
regression approach for classification is not new [24,
25]. The fitted regression coefficients convey the
information of association as well as contribution of
regressors to class labels such as disease status. In the
kernel data setting, the ith regressor is (A, xi), which
records the ith sample tissue similarity with others. As
each regressor represents a tissue effect in terms of
similarity, the regression coefficients can be utilized as
association measure for weighting sample tissue con-
tribution to disease status. Combining the weights and
the standardized expression data matrix A,w eo b t a i na
p-dimensional vector b = A
T ˆ w as weighted expression
genes, where the jth component in b stands for
a weighted summation over all xij, i =1 ,. . . ,n,f o rt h e
jth gene,
b j
j
nj
T
x
x
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In other words, the importance of the jth gene, bj,i sa
weighted average of all n expression levels of this gene,
where the weights are tissue contributions. Ranking the p
components by their absolute values, the resulting
leading genes are candidates for the next step.
Because this kernel-weighting scheme reduces the p genes
to a smaller intermediate candidate subset in which all
expressions are close to being independent, it is useful in
avoiding the curse of dimensionality and filtrating the
dependence among genes. For instance, if the final
search subset is of size q genes, we can first obtain an
intermediate subset of size 10q genes from the original
set of p genes, and next search the q candidate genes
within this 10q intermediate subset, where both q and
10q are predetermined. Within the q-candidate subset,
we re-weight the n tissues and obtain the q absolute
weighted expression sums, denoted as {|bj|, j =1 ,. . . ,q}.
Define the proportion of each |bj|b y
d
b
b
j
j
j j
q =
= ∑ 1
,
this serves as an indication of the relative importance. If
t h ei m p o r t a n c eo ft h e s eq genes are about the same, the
proportion of each gene, δj, would be roughly 1/q.
Therefore, a strict selection criterion would be to retain
all genes with δj larger than 1/q, and remove those with
smaller δj. Other less stringent criteria will be discussed
in the empirical data analysis.
Regularized least squares support vector regression and
classifiers
The RLS-SVR, also known as the ridge support vector
regression, is a least-squares algorithm for solving
support vector regression problems [23]. Here we use
RLS-SVR to estimate the kernel weights in the computa-
tion of gene importance, and next we adopt two
classification methods, kernel Fisher discriminant ana-
lysis (KFDA, [26]) and support vector machine (SVM), to
test the discriminant ability of the final selected genes.
By learning from the given training data, the main goal
of solving a linear regression problem is to find an object
function h(x), h(x)=x
Tθ + b with slope coefficients θ =
(θ1,. . . ,θp)
T and an intercept b, that can correctly predict
the response, y, based on a new input of explanatory
variables, x. For nonlinear extensions by support vector
methods, h is modeled as a linear function of a
BMC Bioinformatics 2009, 10:44 http://www.biomedcentral.com/1471-2105/10/44
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Tz + b,w h e r ez = F(x)i s
the feature map for some function F, which can be
infinite dimensional, such that F(x)
TF(u)=(x, u). The
LS-SVM [23] has the decision function of the form
ak ii
i
n
xx b (, ) , +
= ∑
1
where ai's are the Lagrange multipliers to the optimiza-
tion problem: minθ,b,e Cei i
n 2
1
2 22 //
= ∑ + q subject to
the equality constraints ei = yi - h(xi). Based on the LS-
SVM formulation, here we directly model the response h
as a kernel mixture:
hk () (, ) , xw x x b ii
i
n
=+
= ∑
1
(1)
where w1, w2,. . . ,wn are mixing coefficients. The least-
squares approach is to minimize the square errors of
regression, i.e.,
min | ( )| .
, wb
ii
i
n
yx −
= ∑ h
2
1
(2)
In general, the unique solution of (2) can be determined
numerically. Often the kernel predictor variables, (x,
xi)'s, are highly correlated, thus, the solution of regres-
sion coefficients w will be unstable. This problem can be
solved by adding in a penalty on the norm ||w|| so that
no single coefficient can be too large to reveal high
variance. The regression coefficients are then derived
from the regularized least squares (RLS):
min | ( )| ,
, wb
ii
i
n
C
yx w
2
1
2
2
1
2 −+
⎧
⎨
⎪
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⎬
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⎭ ⎪ = ∑ h (3)
where C controls the trade-off between data goodness of
fit and degree of regularization. The SVR here is
formulated and solved in the primal space. There is a
strong connection between the dual optimization
and primal optimization in terms of regularized least
squares [27].
In this article, the Gaussian kernel k
g (, ) xx e i
xx i =
−−
2
is
used throughout. Let (x, A)b et h ek e r n e lf u n c t i o n s( (x,
x1), ..., (x, xn)), and [( , ) ] , k xx ij i j
n
=1 , denoted as (A, A),
be the kernel datam a t r i x ,w h e r e(xi, xj) represents the
similarity between the ith and jth subjects. Coefficients w
and b are estimated by RLS (3). The estimates of w are the
kernel weights for subject contribution.
Procedures
The procedures of this proposed algorithm are stated as
follows:
Step 1. Standardize row-wise the design matrix, denoted as
A, and calculate the n × n similarity measure matrix (A, A).
Step 2.F i n d ˆ w
(1), the estimated regression coefficients of
the regression model y = (A, A)w
(1) + b
(1) by RLS-SVR,
where y =( y1,. . . ,yn)
T is the n ×1v e c t o ro fc l a s s
memberships and (A, A)i st h em a t r i xo fk e r n e l
similarity. This estimate ˆ w
(1) is used to weight subject
contribution in next step.
Step 3. Set a small number q.L e tb
(1) = A
T ˆ w
(1), I1 be the
indexofthe10qlargest|b j
() 1 |andA
(1)={xj,jŒI1},wherexj
is the jth column of A,a n dA
(1) is an n ×1 0 q matrix.
Step 4. Rerun RLS-SVR for the reduced gene data: y =
(A
(1), A
(1))w
(2) + b
(2). Denote the solution for w by
ˆ w
(2).
Step 5. Similar to Step 3,l e tb
(2) = A
(1)T ˆ w
(2).D e f i n eI2 as
the index of the q largest | b j
() 2 |a n dA
2 ={A j
() 1 , j Œ I2}
where A j
() 1 is the jth column of A
(1).N o t et h a tA
(2) is an
n × q matrix.
Step 6. Solve the regression model y = (A
(2), A
(2))w + b
and obtain the final estimates ˆ w and ˆ b.L e tb =( b1,. . . ,
bq)
T = A
(2)T ˆ w .
Step 7.C a l c u l a t eδj, j =1 ,. . . ,q.D e f i n eI ={ j, δj ≥ 1/q}a n d
 AAj I j =∈ {,}
() 2 ,w h e r e A j
() 2 is the jth column of A
(2).
The resulting  A is the final expression data matrix
consisting of the selected genes.
There are tuning parameter C and kernel parameter g
involved in the gene-selection procedures. In the numerical
study below, we use training data cross-validation (CV) for
parameters selection. Often in CV parameters selection, the
search is over some lattice grid points. To speed up the CV
parameter selection, we suggest to use uniform design
points to replace the lattice grid points [28]. Or one may
start with a crude uniform design search to locate a
candidate setting of parameters and next go on a fine grid
search around the candidate point. All the steps above use
thesamepairof(C,g)obtainedatStep2.Thegene-selection
procedures have been implemented in matlab and R, and
codes are available at http://homepage.ntu.edu.tw/
~ckhsiao/RLS/RLS.htm.
Results
Data sets
We illustrate the proposed algorithm with data from
acute leukemia [1], colon cancer [29], small, round blue
BMC Bioinformatics 2009, 10:44 http://www.biomedcentral.com/1471-2105/10/44
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cancer [32] studies. Once genes are selected, we conduct
classifications to evaluatet h ep e r f o r m a n c eo ft h e s e
genes, and compare with other existing analyses [6, 7,
15, 16, 19, 21, 22].
Acute leukemia study
Samples of the acute leukemia microarray data were
taken from bone marrow or peripheral blood of patients
with acute lymphoblastic leukemia (ALL) or acute
myeloid leukemia (AML). The ALL group can be further
divided into B-cell and T-cell ALL. In other words, the
acute leukemia study can be handled as a binary-class or
a three-class problem. There are 38 training samples and
34 testing samples in total. Among the 38 training cases,
27 are ALL (19 B-cell ALL and 8 T-cell ALL) and 11 are
AML. In the 34 testing samples, 20 are ALL (19 B-cell ALL
and 1 T-cell ALL) and 14 are AML. Each sample contains
7129 gene expressions. The 38 training samples were
used in the proposed algorithm to select genes. To
evaluate the performance of classification with this set of
selected genes, training data were used to train the model
and the 34 testing tissues were next tested to compute
the accuracy.
Colon cancer study
For the colon cancer data set, it consists of 22 normal
and 40 tumor colon tissues. There were originally 6500
genes per tissue, and 2000 expressions of the highest
minimal intensity across tissues were selected. Because
this data set was not split into training and testing sets,
we considered all samples in the procedures of gene
selection. Based on the set of selected genes, we
performed a 5-fold cross-validation 10 times to examine
the performance in classification.
Small, round blue cell tumors data
This data set contains four types of small, round blue cell
tumors of childhood, including neuroblastoma, rhabdo-
myosarcoma, non-Hodgkin lymphoma and Ewing
family of tumors. There were 63 training and 25 testing
samples (5 testing samples belong to other types, and
hence were removed from the testing set). The original
number of genes is 6567 for each sample. Genes were
excluded if their intensities are too low. The final
number of genes remained for analysis was 2308.
Again, only training data were used to perform gene
selection.
Breast cancer study
This study investigated 3226 gene expression profiles to
identify the gene set that can discriminate three types of
breast cancer: the BRCA1-mutation, BRCA2-mutation,
and sporadic cases. It is a three-class problem. There were
seven samples in the first class, eight in the second, and
seven in the third. All 22 samples were used to perform
the procedures for gene selection, and a leave-one-out
approach is adopted for classification validation.
Lung cancer study
This study examined the ability of discrimination with
microarray data in identifying five subclasses of human
lung carcinomas, including adenocarcinomas, squamous
cell lung carcinomas, pulmonary carcinoids, small-cell
lung carcinomas cases, and normal lung specimens. A
total of 203 tissues were collected and there were 139,
21, 20, 6, and 17 samples in these five classes,
respectively. The 3312 most variably expressed genes
among 12600 transcript sequences were included in the
data. Again, all samples were used in the procedures of
gene selection, and a 5-fold cross-validation is per-
formed 10 times to evaluate classification accuracy.
Classification methods
To evaluate the performance of the proposed gene
selection algorithm, we conduct the classification using
only selected genes. Here, two classifiers are utilized, the
kernel Fisher discriminant analysis (KFDA, [26]) and
SVM (a smoothing SVM algorithm [33] is adopted for
solving SVM solutions in our data analysis). When it
comes to multiclass problems, KFDA can be applied
directly; while SVM adopts the winner-takes-all in one-
against-one voting. The resulting accuracy is compared
with others, denoted as BVS (Bayesian variable selection)
[19], BMA (Bayesian model average) [21], SGS1 and
SGS2 (stable gene selection) methods based on two
ranking scores [7], IFFS (incremental forward feature
selection) [16], SVM-RFE (SVM recursive feature elim-
ination) [15], EB (entropy-based) [6], and MBGS (multi-
class Bayesian gene selection) [22], respectively. The
SVM-RFE, BVS and IFFS can only deal with binary-class
problems. For IFFS, Lee et al. [16] applied the directed
acyclic graph model and converted this problem into
two binary classification procedures. For instance, for the
three-class leukemia, IFFS solves a two-step classification
problem. The first step is to split ALL and AML (there are
1 4g e n e ss e l e c t e di nt h i ss t e p ) ,a n dt h es e c o n ds t e pi st o
further classify B-cell from T-cell within the ALL class
(there are 9 genes selected in this step using the
remaining 7115 genes). Furthermore, if the list of
selected genes was provided in the above references, we
perform the KFDA and SVM classifications, respectively,
to compare the performance of various selection sets.
Selected genes and classification ability
Acute leukemia study
T a b l e s1a n d2l i s tt h es e l e c t e df i n a lq genes in the
candidate subset of leukemia data with two classes and
BMC Bioinformatics 2009, 10:44 http://www.biomedcentral.com/1471-2105/10/44
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the same data (SVM-REF by [15], and BVS by [19]), we
assume the number of responsible genes is no larger
than 10 and set q =1 0h e r e .I nT a b l e s1a n d2 ,t h ef i r s t
column represents the absolute weighted sum, denoted
by |bj|, of gene expressions for the q genes, where the
sum is taken over all weighted subjects in the training
set. The second column lists δj, the proportion of |bj |i n
all q |b|'s. The third column is the cumulative sum of
proportions, i.e., d j j
l ∑ , l =1 ,. . . ,q.T h ei n d i c e so ft h e s e
q genes in the original data and gene descriptions are
listed in the last column. When 10 is determined ap r i o r i
for the size of influential genes, these 10 genes ought to
be reported. Alternatively, if one considers this set not
small enough, a threshold of 1/q can be adopted. For
instance, the top 4 genes in Table 1 and the top 5 genes
in Table 2 all correspond to δj ≥ 1/10. This choice,
however, usually results in a small set of candidate genes.
Other set of a moderate size can include j*g e n e s ,w h e r e
d j j
j
=
∗
∑ 1 ≥ 80%, such as the first 7 genes in both Tables 1
and 2. In the following analysis, we select genes based on
the strict 1/q criterion, the intermediate 80% threshold,
and the largest set of all q genes, respectively; and we
examine, for each selection criterion, the corresponding
classification accuracy. Results from others are also listed
for comparison [6, 15, 16, 19, 21].
The upper half in Table 3 is binary-class and the lower
half is for three-class. The table is sub-divided into
three parts, A, B, and C, where part A includes results
from our RLS-SVR approach and the corresponding
classification accuracy, B includes other gene selection
methods with the KFDA and SVM classifiers, respec-
tively, and C simply lists the reported results in other
works. For example, the lists of selected genes were
provided based on BVS [19] and BMA [21], thus the
same lists were used to classify the testing cases with
KFDA or SVM in part B. In addition, we apply the
stable gene selection methods (SGS1 and SGS2 [7]) to
select 10 genes and then classify with KFDA or SVM
for comparison (part B). In contrast, the set based on
IFFS [16] was not provided and therefore we report
only the accuracy in part C. For the binary-class in
leukemia data, when the strict 1/q criterion is adopted,
the RLS-SVR selects 4 genes and both KFDA and SVM
attain an accuracy of 0.9412, same as that of BMA
with 20 selected genes (there is only one gene in
common). Using the 80% threshold, the proposed
algorithm selects 7 genes and both KFDA and SVM
attain an accuracy of 1; while IFFS takes 14 genes to
reach the same accuracy. If all q (q = 10) genes are
selected, both classifiers reach accuracy of 1; while
SGS1 and SGS2 achieve less accurate results.
Table 1: The gene weighted sums, proportions, cumulative proportions, and corresponding gene numbers of the selected genes in
acute leukemia data with two classes
Weighted sum |bj| Proportion δj Cumulative proportions Gene number Description [1]
150.6797 0.1847 0.1847 6201 interleukin-8 precursor
125.3594 0.1536 0.3383 1882 CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)
117.9711 0.1446 0.4829 2402 Azurocidin gene
92.7434 0.1137 0.5966 5552 probable G protein-coupled receptor LCR1 homolog
72.3649 0.0887 0.6853 1779 MPO Myeloperoxidase
69.6762 0.0854 0.7707 6181 PTMA gene extracted from Human prothymosin alpha mRNA
64.7264 0.0793 0.8500 1763 Thymosin beta-4 mRNA
61.0759 0.0749 0.9249 2345 G-gamma globin gene extracted from H. sapiens G-gamma
globin and A-gamma globin genes's
55.6241 0.0682 0.9931 5308 GDP-dissociation inhibitor protein (Ly-GDI) mRNA
5.6697 0.0069 1 5648 HLA-B null allele mRNA
Table 2: The gene weighted sums, proportions, cumulative proportions, and corresponding gene numbers of the selected genes in
acute leukemia data with three classes
Weighted sum |bj|P r o p o r t i o n δj Cumulative proportions Gene number Description [1]
206.1576 0.1583 0.1583 6201 interleukin-8 precursor
196.3753 0.1508 0.3091 1674 FTL Ferritin, light polypeptide
155.8362 0.1196 0.4287 1882 CST3CystatinC(amyloidangiopathyandcerebralhemorrhage)
143.1404 0.1099 0.5386 5552 probable G protein-coupled receptor LCR1 homolog
141.0207 0.1083 0.6469 2402 Azurocidin gene
120.1933 0.0923 0.7392 6209 VIM Vimentin
112.4293 0.0863 0.8255 4017 HLAclassIIhistocompatibilityantigen,DRalphachainprecursor
96.7316 0.0743 0.8998 5716 RPS3 Ribosomal protein S3
83.2569 0.0639 0.9637 1779 MPO Myeloperoxidase
47.4576 0.0364 1 5648 HLA-B null allele mRNA
BMC Bioinformatics 2009, 10:44 http://www.biomedcentral.com/1471-2105/10/44
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(page number not for citation purposes)The lower half of Table 3 displays the accuracy for the
three-class leukemia classification. The strict 1/q and
80%-cutoff criteria select 5 and 7 genes, respectively.
Both KFDA and SVM classification rule with 7 selected
genes reach an accuracy of 1. With the same classifiers
KFDA and SVM, other gene selection procedures, BMA,
SGS1, and SGS2 achieve less accuracy with more genes.
When considering selection and classification together,
IFFS and BMA attain the same or higher accuracy, but
require more genes (23 for IFFS and 15 for BMA). In the
three-class case, RLS-SVR+KFDA and RLS-SVR+SVM out-
perform the rest, since they reach the best accuracy with a
much less number of genes than others. It is noticeable
that our method does not depend on the data structure,
and its computation is easy and fast. In contrast, IFFS
and SVM-REF require iterations, and BVS and BMA
involve the simulation of posterior samples from
MCMC.
Colon cancer study
Similar to Tables 1 and 2, Table 4 lists the information of
the q candidate genes of the colon cancer data. Again, we
let q = 10 based on the information from earlier analysis
in [15, 16]. Here, the threshold 1/10 = 0.1 leads to 4
genes in the final model; while 80% threshold selects 5
genes. The accuracies of colon cancer in Table 5 are mean
accuracies of 10 replicate runs of a random 5-fold
partition for cross-validation and the last column
contains the standard deviations of accuracies in these
10 replicate runs. The best accuracy is 0.94 by RLS-SVR
with KFDA using 10 genes. It is higher than SGS and
other methods. SVM-RFE was conducted based on one
particular split of the 62 samples into 31 training and 31
testing sets and the accuracy is 0.9032; and EB adopted
the leave-one-out cross-validation with accuracy 0.919.
Small, round blue cell tumors data
The information of q-candidate subset for the SRBCT
data is in Table 6. The numbers of selected genes are 2
and 8 with the threshold levels 0.1 and 80%, respec-
tively. The best accuracy in Table 7 is 1 with 10 genes by
RLS-SVR with either KFDA or SVM. Note that it takes 14
genes for EB to reach the same accuracy.
Breast cancer
Table 8 states the information of the q candidate genes for
thebreastcancerstudy,andTable9containsclassification
accuracies with selected genes. There are 4 and 7 genes
selected under the 0.1 and 80% thresholds, respectively.
The best accuracy is 0.9545 (only one is misclassified)
based on 10 genes. MBGS attains the highest accuracy,
while results of SGS with two classifiers are similar to
ours. Since BMA selects the most significant genes within
each training set (BMA also adopts leave-one-out cross-
validation), different genes are selected in different
training validation sets (13–18 genes).
Lung cancer
The information of q candidate genes and the classifica-
tion results for the lung cancer data are listed in Tables 10
and 11, respectively. Five and seven genes are selected
under the 0.1 and 80% criteria, respectively. The best
Table 3: Testing accuracies under different procedures for the
acute leukemia data
Binary classes
Procedures Classifier No. of genes Accuracy
A: Proposed selection and criterion
RLS-SVR
δj ≥ 1/q +KFDA 4 0.9412
+SVM 4 0.9412
∑ δj ≥ 80% +KFDA 7 1
+SVM 7 1
q genes +KFDA 10 1
+SVM 10 1
B: Other selection procedures
BVS +KFDA 5 0.9706
+SVM 5 0.9706
BMA +KFDA 20 1
+SVM 20 1
SGS1 +KFDA 10 0.9118
+SVM 10 0.9118
SGS2 +KFDA 10 0.9412
+SVM 10 0.9412
C: Selection and classification together
IFFS 14 1
SVM-RFE 8 1
BVS 5 0.9706
BMA 20 0.9412
Three classes
Procedures Classifier No. of genes Accuracy
A: Proposed selection and criterion
RLS-SVR
δj ≥ 1/q +KFDA 5 0.7353
+SVM 5 0.9118
∑ δj ≥ 80% +KFDA 7 1
+SVM 7 1
q genes +KFDA 10 0.9706
+SVM 10 0.9412
B: Other selection procedures
BMA +KFDA 15 0.9706
+SVM 15 0.9706
SGS1 +KFDA 10 0.9118
+SVM 10 0.8529
SGS2 +KFDA 10 0.8824
+SVM 10 0.8529
C: Selection and classification together
IFFS 23 1
BMA 15 0.9706
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(page number not for citation purposes)result is 0.9222 using 10 genes with SVM. Both SGS1 and
SGS2 can attain better accuracy if more genes (98 here)
are included.
Discussions
We propose in this article a new algorithm that identifies
influential genes with rich information for classification.
This approach allows the collected tissues to provide
different strength of association with the disease. In
other words, patients sharing similar gene expressions
contribute in a similar way. The similarity between
tissues is quantified via kernel functions, and RLS-SVR is
applied to compute the kernel weights for tissue
contribution. Genes are then selected based on their
weighted expression sums. The results of empirical data
analysis show that the proposed selection procedure
performs better in the sense that it attains a higher
accuracy based on fewer genes. Furthermore, the
proposed gene selection method is not restricted to
binary-class problems. It handles the multiclass
responses directly. Although Lee et al. [16] dealt with
the 3-type leukemia case, their method assumed the
knowledge of a hierarchical structure of the three types of
leukemia. This hierarchy property may not be common
for other multiclass problems; and if it is, the knowledge
may not be known ap r i o r i . When the number of genes
increases, the computation of BMA [21], EB [6], and
MBGS [22] become heavy and some pre-selection
process may be needed. Yang et al. proposed two
methods to rank the genes [7]. Their algorithms are
fast, but require more genes to achieve a higher
classification accuracy. In contrast, the implementation
of our proposed procedures is easy, fast and accurate. In
our algorithm, the most intensive computation involves
solving the inverse of an n × n matrix in regression. Since
n is usually small, there is no obvious computational
l o a d .F u r t h e r m o r e ,o t h e rapproaches often rely on
iterations to find the ranking orders of genes; while our
SVR-weight based procedures require only one run of
seven steps.
There are several issues to be discussed. First, we have set
q = 10 in our experimental studies, and reduce from an
intermediate subset of size 10q genes to a candidate
subset of size q. We assign 10 for q under the assumption
that no more than 10 genes will be included in further
investigations. When other information is available, this
value can be determined with ease. In our experience, the
number 10q for the size of an intermediate set is fairly
robust. Other choices do not alter the results much.
V a r y i n gt h i sn u m b e ro n l yc h a n g e ss l i g h t l yt h eo r d e ro f
genes in the final step. Figure 1 represents the accuracies
of the five data sets with q genes, where q =1 ,2 ,. . . ,1 0 ,
respectively. The accuracy increases with the number of
genes and remains stable near q = 10. Hence, setting 10
Table 4: The gene weighted sums, proportions, cumulative proportions, and corresponding gene numbers of the selected genes in
colon cancer data
Weighted sum |bj| Proportion δj Cumulative proportions Gene number Description [29]
33.2835 0.2522 0.2522 164 interferon-inducible protein 1-8D (human); contains MSR1
repetitive element
28.4860 0.2158 0.4860 1378 80.7KDalphatrans-inducingprotein(Bovineherpesvirustype1)
21.0143 0.1592 0.6272 115 H. sapiens p27 mRNA
13.9334 0.1056 0.7328 249 human desmin gene, complete cds.
10.4369 0.0791 0.8119 13 H. sapiens ACTB mRNA for mutant beta-actin (beta'-actin)
8.2575 0.0626 0.8745 16 human tra1 mRNA for human homologue of murine tumor
rejection antigen gp96
5.9915 0.0454 0.9199 33 40S robosomal protein S24 (human)
5.8151 0.0441 0.9640 167 IG lambda chain C regions (human)
3.7171 0.0282 0.9922 14 myosin light chain ALKALI, smooth-muscle iosform (human)
1.0403 0 0079 1 44 ubiquitin (human)
Table 5: Testing accuracies under different procedures for colon
cancer data
Procedures Classifier No. of genes Accuracy SD
A: Proposed selection and criterion
RLS-SVR
δj ≥ 1/q +KFDA 4 0.9250 0.0083
+SVM 4 0.9067 0.0082
∑ δj ≥ 80% +KFDA 5 0.9200 0.0163
+SVM 5 0.9183 0.0157
q genes +KFDA 10 0.9400 0.0186
+SVM 10 0.9300 0.0167
B: Other selection procedures
EB +KFDA 9 0.9283 0.0076
+SVM 9 0.9200 0.0194
SGS1 +KFDA 10 0.925 0.0083
+SVM 10 0.9100 0.0153
SGS2 +KFDA 10 0.9283 0.0076
+SVM 10 0.9100 0.0186
C: Selection and classification together
IFFS 5 0.8806 0.0167
SVM-RFE 8 0.9032 n.a.
EB 9 0.919 n.a.
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(page number not for citation purposes)for q may be large enough to capture the influential
genes. Second, as we have pointed out in previous
sections, the proportion δj is helpful in determining the
final number of selected genes. The threshold for the
number of genes to be selected can be set at different
levels. If the researcher prefers a parsimonious model, he
or she can set the cutting point at 1/q for δj .I fm o r e
information is desired, the value can be set at the 80%
cutoff, or one can simply include all q genes. It can be
seen from Figure 1 that the accuracy with respect to the
80% cutoff is close to that with all q genes. In unreported
analyses, we also tried 75% and 90% as the threshold
levels and have obtained similar results. Finally, we
define in this article the subject weights via regressing
Table 6: The gene weighted sums, proportions, cumulative proportions, and corresponding gene numbers of the selected genes in
SRBCT data
Weighted sum |bj|P r o p o r t i o n δj Cumulative proportions Gene number Description [30]
366.2124 0.2283 0.2283 509 human DNA for insulin-like growth factor II (IGF-2); exon 7
and additional ORF
293.0313 0.1727 0.4110 187 insulin-like growth factor 2 (somatomedin A)
139.3697 0.0869 0.4979 246 caveolin 1, caveolae protein, 22 kD
130.3774 0.0813 0.5792 1955 fibroblast growth factor receptor 4
120.8319 0.0753 0.6545 1645 olfactomedinrelated ER localized protein
118.9978 0.0742 0.7287 545 antigen identified by monoclonal antibodies 12E7, F21 and O13
110.2948 0.0688 0.7975 1954 follicular lymphoma variant translocation 1
109.6586 0.0684 0.8659 1389 Fc fragment of IgG, receptor, transporter, alpha
108.1788 0.0674 0.9333 1372 nucleolin
107.1303 0.0667 1 430
Table 7: Testing accuracies under different procedures for
SRBCT data
Procedures Classifier No. of genes Accuracy
A: Proposed selection and criterion
RLS-SVR
δj ≥ 1/q +KFDA 2 0.6
+SVM 2 0.55
∑ δj ≥ 80% +KFDA 8 0.95
+SVM 8 0.95
q genes +KFDA 10 1
+SVM 10 1
B: Other selection procedures
EB +KFDA 14 1
+SVM 14 1
SGS1 +KFDA 10 0.8
+SVM 10 0.7
SGS2 +KFDA 10 0.85
+SVM 10 0.85
C: Selection and classification together
EB 14 1
Table 8: The gene weighted sums, proportions, cumulative
proportions, and corresponding gene numbers of the selected
genes in breast cancer data
Weighted sum |bj| Proportion δj Cumulative
proportions
Gene
number
68.8881 0.1897 0.1897 422
49.4341 0.1361 0.3258 2886
45.0788 0.1241 0.4499 1612
42.2519 0.1163 0.5662 114
39.0654 0.1076 0.6738 1066
29.6513 0.0816 0.7554 3023
25.4254 0.0700 0.8254 719
25.0111 0.0689 0.8943 1084
20.1092 0.0554 0.9496 497
18.2996 0.0504 1 1561
Table 9: Testing accuracies under different procedures for breast
cancer data
Procedures Classifier No. of genes Accuracy
A: Proposed selection and criterion
RLS-SVR
δj ≥ 1/q +KFDA 5 0.9091
+SVM 5 0.9545
∑ δj ≥ 80% +KFDA 7 0.9091
+SVM 7 0.9545
q genes +KFDA 10 0.9545
+SVM 10 0.9545
B: Other selection procedures
MBGS +KFDA 10 0.9545
+SVM 10 1
SGS1 +KFDA 10 0.9091
+SVM 10 0.9545
SGS2 +KFDA 10 0.9091
+SVM 10 0.9545
C: Selection and classification together
BMA 13–18 0.7273
MBGS 10 1
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(page number not for citation purposes)class labels on kernel data. The class labels are denoted
as 1, 2, ..., and J, which can be replaced by other
representations. For instance, the optimal scores [25] of
the first leading component would be a good choice.
This may improve the performance of regularization
least squares regressions. Further investigations are
worth pursuing.
Conclusion
In conclusion, with unequal kernel weights on tissues,
the proposed gene selection algorithm can detect the
most influential genes and obtain a higher accuracy with
a less number of genes. In addition, no classifier is
involved during the search of significant genes. In other
words, the selected genes will not depend on or be
restricted to the classifiers. For instance, the accuracies
under RLS-SVR+KFDA and RLS-SVR+SVM are quite
similar, which supports that the selected genes are
important regardless of the classifier.
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Table 10: The gene weighted sums, proportions, cumulative proportions, and corresponding gene numbers of the selected genes in
lung cancer data
Weighted sum |bj| Proportion δj Cumulative proportions Gene number Description [32]
211.3186 0.1600 0.1600 732 GRO2 oncogene
208.0781 0.1576 0.3176 2722 ligand of neuronal nitric oxide synthase with carboxyl-terminal
PDZ domain
191.642 0.1451 0.46278 2194 fatty acid binding protein 7, brain
158.3931 0.1200 0.5827 3243 bridging integrator 1
142.839 0.1082 0.6909 2010 progesterone binding protein
121.546 0.0921 0.7830 2096 interferon regulatory factor 3
106.1448 0.0804 0.8634 1881 occludin
102.9994 0.0780 0.9414 2987 apoptosis-associated tyrosine kinase
46.473 0.0352 0.9766 215 ribonuclease, RNase A family, 1 (pancreatic)
30.9358 0.0234 1 270 UNC13 (C. elegans)-like
Table 11: Testing accuracies under different procedures for lung
cancer data
Procedures Classifier No. of genes Accuracy SD
A: Proposed selection and criterion
RLS-SVR
δj ≥ 1/q +KFDA 5 0.903 0.0082
+SVM 5 0.9051 0.0111
∑ δj ≥ 80% +KFDA 7 0.9179 0.0059
+SVM 7 0.9097 0.0065
q genes +KFDA 10 0.9222 0.009
+SVM 10 0.9071 0.0104
B: Other selection procedures
SGS1 +KFDA 10 0.9005 0.0062
+SVM 10 0.9005 0.0052
SGS2 +KFDA 10 0.8077 0.0164
+SVM 10 0.8513 0.0015
C: Selection and classification together
SGS1 98 0.938 n.a.
SGS2 99 0.931 n.a.
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Accuracies with respect to different numbers of
genes.
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